ABCG2 - ATP binding cassette subfamily G member 2 (Junior blood group) Gene
Species: Macaca fascicularis
Gene Type: protein coding
Gene ID: 102140529
About ABCG2
Primary_assembly 5: 85,708,548-85,769,675 reverse strand.Macaca_fascicularis_6.0:CM021943.1
This gene has 1 transcript (splice variant), 344 orthologues and 4 paralogues.
ABCG2 Products (10)
| mRNA | Protein | Name |
|---|---|---|
| XM_045393352.1 | XP_045249287.1 | broad substrate specificity ATP-binding cassette transporter ABCG2 isoform X1 |
| XM_045393349.1 | XP_045249284.1 | broad substrate specificity ATP-binding cassette transporter ABCG2 isoform X1 |
| XM_045393355.1 | XP_045249290.1 | broad substrate specificity ATP-binding cassette transporter ABCG2 isoform X1 |
| XM_045393351.1 | XP_045249286.1 | broad substrate specificity ATP-binding cassette transporter ABCG2 isoform X1 |
| XM_045393356.1 | XP_045249291.1 | broad substrate specificity ATP-binding cassette transporter ABCG2 isoform X2 |
| XM_005555388.3 | XP_005555445.1 | broad substrate specificity ATP-binding cassette transporter ABCG2 isoform X2 |
| XM_045393350.1 | XP_045249285.1 | broad substrate specificity ATP-binding cassette transporter ABCG2 isoform X1 |
| XM_045393354.1 | XP_045249289.1 | broad substrate specificity ATP-binding cassette transporter ABCG2 isoform X1 |
| XM_045393353.1 | XP_045249288.1 | broad substrate specificity ATP-binding cassette transporter ABCG2 isoform X1 |
| XM_045393348.1 | XP_045249283.1 | broad substrate specificity ATP-binding cassette transporter ABCG2 isoform X1 |
ABCG2 Protein Structure
3a01204
3a01204: cl36780 (45 - 648)
- 0
- 200
- 400
- 600
- 655 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
broad substrate specificity ATP-binding cassette transporter ABCG2 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-10440 | Vismodegib | 99.97% | Yes | |
| HY-101561 | Avapritinib | Inhibitor | 99.85% | Yes |
| HY-109061 | Lazertinib | 99.87% | Unkown |
Clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-109019 | Vorolanib | Inhibitor | 99.78% | Phase 3 |
| HY-101570 | Nedisertib | 99.70% | Phase 2 | |
| HY-10527C | Telatinib mesylate | Inhibitor | 99.74% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(58)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-10010 | Ko 143 | Inhibitor | 99.97% | Unkown |
| HY-11079 | A-803467 | Inhibitor | 99.69% | Unkown |
| HY-N2143 | Fumitremorgin C | Inhibitor | 99.92% | Unkown |
| HY-101453 | Ceefourin 1 | Inhibitor | 99.72% | Unkown |
| HY-10873 | N-Desethyl Sunitinib | 99.81% | Unkown | |
| HY-12757 | YHO-13177 | Inhibitor | 99.65% | Unkown |
| HY-D2869 | Ac-H-FluNox | 99.88% | Unkown | |
| HY-109061B | Lazertinib mesylate | 99.85% | Unkown | |
| HY-12758 | YHO-13351 | Inhibitor | 99.16% | Unkown |
| HY-136450 | Triclabendazole sulfoxide | Inhibitor | 98.34% | Unkown |
| HY-18010 | PCI 29732 | Inhibitor | 99.59% | Unkown |
| HY-111678 | ML230 | Inhibitor | 99.65% | Unkown |
| HY-100933 | MY-5445 | Inhibitor | 99.79% | Unkown |
| HY-113805 | MC70 | Inhibitor | 99.50% | Unkown |
| HY-144305 | KPH2f | Inhibitor | 99.22% | Unkown |
| HY-112505 | Efflux inhibitor-1 | Inhibitor | 98.0% | Unkown |
| HY-151432 | URAT1 inhibitor 3 | Inhibitor | 98.02% | Unkown |
| HY-P5391 | LL-37(17-32) | Inhibitor | 96.71% | Unkown |
| HY-RS00077 | ABCG2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W049875 | Nitroxynil | 98.92% | Unkown | |
| HY-183623 | ProAlk01 | Inducer | / | Unkown |
| HY-101570G | Nedisertib (GMP) | Inhibitor | / | Unkown |
| HY-109061A | Lazertinib mesylate hydrate | / | Unkown | |
| HY-118083 | Pentamethoxymorin | Inhibitor | / | Unkown |
| HY-121645 | 2,4-Dibromoestradiol | / | Unkown | |
| HY-122416 | 6,8-Diprenylnaringenin | Inhibitor | / | Unkown |
| HY-129301 | CCTA-1523 | Inhibitor | / | Unkown |
| HY-136450S | Triclabendazole sulfoxide-d3 | Inhibitor | / | Unkown |
| HY-136450S1 | Triclabendazole sulfoxide-13C,d3 | Inhibitor | / | Unkown |
| HY-13774 | WK-X-34 | Inhibitor | / | Unkown |
| HY-146676 | UR-MB108 | Inhibitor | / | Unkown |
| HY-155652 | ABCG2-IN-1 | Inhibitor | / | Unkown |
| HY-155653 | ABCG2-IN-2 | Inhibitor | / | Unkown |
| HY-156092 | Antitumor photosensitizer-4 | / | Unkown | |
| HY-168573 | AZ99 | Inhibitor | / | Unkown |
| HY-170396 | ABCG2-IN-4 | Inhibitor | / | Unkown |
| HY-174435 | ABCB1/ABCG2-IN-1 | Inhibitor | / | Unkown |
| HY-17648 | MBL-II-141 | Inhibitor | / | Unkown |
| HY-178100 | PARP1-IN-45 | Inhibitor | / | Unkown |
| HY-178386 | ABCG2-IN-5 | Inhibitor | / | Unkown |
| HY-181731S | (R,S,R)-Altenuene-13C15 | / | Unkown | |
| HY-181802 | MRS8431 | / | Unkown | |
| HY-181803 | MRS8432 | / | Unkown | |
| HY-181804 | MRS8288 | Inhibitor | / | Unkown |
| HY-182000 | Xanthine oxidase-IN-23 | / | Unkown | |
| HY-D3179 | CDg13 | Substrate | / | Unkown |
| HY-RS00078 | Abcg2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS00079 | Abcg2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W082856A | Butein tetramethyl ether | Inhibitor | / | Unkown |
| HY-119724 | ABCG2-IN-3 | Inhibitor | / | Unkown |
| HY-123526 | NSC265473 | / | Unkown | |
| HY-136450R | Triclabendazole sulfoxide (Standard) | Inhibitor | / | Unkown |
| HY-149469 | 3,7,2',4'-Tetramethoxy-5-hydroxyflavone | Inhibitor | / | Unkown |
| HY-168572 | MZ82 | Inhibitor | / | Unkown |
| HY-N2651 | 5,7,3'-Trihydroxy-4'-Methoxy-8-prenylflavanone | Inhibitor | / | Unkown |
| HY-W705354 | Vismodegib-d4 | / | Unkown | |
| HY-W716916 | Vismodegib-d7 | / | Unkown | |
| HY-W754911 | Avapritinib-d3 | Inhibitor | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service